Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Prevalence of ATM in the general population is estimated at 1–4 new cases per million per year, while in SLE it is seen in 1–2% of patients, 1000 times greater than the general population.
A 29-year-old female, previously healthy, presented with a 2-week history of bilateral eye puffiness and increased abdominal girth, followed by bilateral lower limb oedema and reduced urine output. She noted to have reduced movement in her lower limbs with foot drop and reduced reflexes bilaterally, power 2/5 in the right foot distally, 1/5 in the left foot. The patient had mouth ulcers, excessive hair fall but denied skin rashes, joint pain, chest pain, or abdominal pain. Laboratory investigations showed normal creatinine, urinary protein creatinine ratio 0.9 g/g with microscopic haematuria. Immunological workup showed positive Antinuclear antibodies, double-stranded DNA, and both complement C3 and C4 were low; lupus anticoagulants were negative.
She had a CT with contrast for the chest, abdomen, and pelvis, which revealed a pulmonary embolism. She was started on therapeutic anticoagulation, for which a planned kidney biopsy was declined, and cyclophosphamide 500 mg iv with pulse steroids 1 g daily for 3 days, along with a desensitization dose of trimethoprim sulfamethoxazole and bone prophylaxis and hydroxychloroquine. An MRI of her spinal cord was suggestive of transverse myelitis. A multidisciplinary team discussion regarding the treatment concluded to start therapeutic plasma exchange for severe Systemic lupus erythematosus with transverse myelitis. She showed improvement following the second session and planned to complete 7 sessions.
Improvement in neurological signs could be partially due to the effect of immunosuppression, which eased the spinal cord edema, not to plasma exchange alone in this case. Myelitis can also occur years following SLE diagnosis.
